SCHEMBL221852

SCHEMBL221852

[CH2]CCOCCOCCOCC[CH2]

nearest known ligand 0.38

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
TSHR P16473 3/20 0.31
MAPK1 P28482 1/20 0.31
ALDH1A1 P00352 2/20 0.30
TP53 P04637 2/20 0.30
HIF1A Q16665 2/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL218216 1.00 MEN1 (0.38) MEN1KMT2ATSHRMAPK1ALDH1A1
SCHEMBL220570 0.95
SCHEMBL4257983 0.89 MEN1 (0.32) MEN1KMT2A
SCHEMBL219996 0.89
SCHEMBL8468107 0.86 MEN1 (0.30) MEN1KMT2A
SCHEMBL9648110 0.86 MEN1 (0.30) MEN1KMT2A
SCHEMBL4251521 0.86
SCHEMBL3673825 0.84 TSHR (0.30) TSHR
SCHEMBL3683039 0.84 TSHR (0.30) TSHR
SCHEMBL220749 0.84 MEN1 (0.32) MEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070197820-A1 Process for producing urethane (meth)acrylates and new urethane (meth)acrylates CYTEC SURFACE SPECIALITES, S.A. (BE) 2007-08-23 US claimed
EP-1747194-A1 PROCESS FOR PRODUCING URETHANE (METH)ACRYLATES AND NEW URETHANE (METH)ACRYLATES CYTEC SURFACE SPECIALTIES, S.A. (BE) 2007-01-31 EP claimed
WO-2005110978-A1 PROCESS FOR PRODUCING URETHANE (METH)ACRYLATES AND NEW URETHANE (METH)ACRYLATES CYTEC SURFACE SPECIALTIES, S.A. (BE) 2005-11-24 WO claimed
EP-0153907-B1 COMPOUNDS CONTAINING PIPERIDINE AND THEIR USE IN THE STABILISATION OF SYNTHETIC POLYMERS CIBA-GEIGY AG (CH) 1992-11-11 EP claimed
US-20240166815-A1 POLYMERIC AMINO (METH)ACRYLATE ALLNEX BELGIUM, S.A. (BE) 2024-05-23 US disclosed
EP-3929256-B1 POLYMERIC AMINO (METH)ACRYLATE ALLNEX Belgium SA (BE) 2024-01-24 EP disclosed
EP-2560948-B2 RADIATION CURABLE AMINO(METH)ACRYLATES ALLNEX Belgium SA (BE) 2023-07-12 EP disclosed
US-20230151222-A1 AMINO (METH)ACRYLATES ALLNEX BELGIUM S.A. (BE) 2023-05-18 US disclosed
CN-115698195-A Polymeric amino (meth) acrylates 湛新比利时股份有限公司 2023-02-03 CN disclosed
CN-109415507-B Thermoplastic polyamide particles 巴斯夫欧洲公司 2022-03-08 CN disclosed
WO-2021259701-A1 POLYMERIC AMINO (METH)ACRYLATE ALLNEX BELGIUM, S.A. (BE) 2021-12-30 WO disclosed
EP-3929256-A1 POLYMERIC AMINO (METH)ACRYLATE Allnex Belgium, S.A. (BE) 2021-12-29 EP disclosed
EP-0517658-A1 Stabilisation of polymeric organic materials by using synergistic mixtures comprising sterically hindered cyclic amines and derivatives of 3-pyrazolidinone or 1,2,4-triazolidine-3,5-dione CIBA-GEIGY AG (CH) 1992-12-09 EP disclosed
EP-0153907-B1 COMPOUNDS CONTAINING PIPERIDINE AND THEIR USE IN THE STABILISATION OF SYNTHETIC POLYMERS CIBA-GEIGY AG (CH) 1992-11-11 EP disclosed
EP-0508940-A1 Process for preparing 2,2,6,6-tetra-methyl-4-piperidylamines CIBA-GEIGY AG (CH) 1992-10-14 EP disclosed
US-5130429-A Methylation with formaldehyde in a solvent and distillation CIBA-GEIGY CORPORATION (US) 1992-07-14 US disclosed
EP-0319480-A2 Process for the methylation of triazine compounds containing 2,2,6,6-tetramethylpiperidine groups CIBA-GEIGY AG (CH) 1989-06-07 EP disclosed
EP-0302020-A2 Process for the preparation of 2,2,6,6-tetramethyl-4-piperidyl-amines CIBA-GEIGY AG (CH) 1989-02-01 EP disclosed
US-4618634-A 2,2,6,6-TETRAMETHYLPIPERIDIN-4YL)ALKOXY-AMIDES CIBA-GEIGY S.P.A. (IT) 1986-10-21 US disclosed
EP-0153907-A2 Compounds containing piperidine and their use in the stabilisation of synthetic polymers CIBA-GEIGY AG (CH) 1985-09-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197820-A1 Process for producing urethane (meth)acrylates and new urethane (meth)acrylates USP9X, NAT10, ADCY10 MEN1 530/4885KMT2A 1016/4885TSHR 1429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.